News

AABB creates new guidelines for platelet transfusion


 

Platelets for transfusion

The AABB has developed new guidelines that specify situations

in which adults should receive platelet transfusions.

The group’s

recommendations are based on results of a systematic review.

The

suggestions cover several clinical situations in which platelet

transfusions might be an option, such as therapy-induced hypoproliferative thrombocytopenia, central venous catheter placement, diagnostic lumbar puncture, and cardiac surgery.

To formulate the guidelines, researchers conducted a review of randomized clinical trials and observational studies published from 1900 through September 2014. All studies reported clinical outcomes in patients receiving prophylactic or therapeutic platelet transfusions.

Based on the collected data, the AABB now strongly recommends prophylactic platelet transfusions to reduce the risk for spontaneous bleeding in hospitalized adults with therapy-induced hypoproliferative thrombocytopenia and a platelet count of 10 x 109 cells/L or less. The recommendation states that transfusing 0.5 to 1 apheresis unit is sufficient in these patients.

A weaker recommendation is that prophylactic platelet transfusions be given to patients undergoing elective central venous catheter placement who have a platelet count of less than 20 x 109 cells/L.

Likewise, the AABB says prophylactic transfusions should be given to patients having elective diagnostic lumbar puncture or major elective nonneuraxial surgery who have a platelet count less than 50 x 109 cells/L.

Another weak recommendation advises against routine prophylactic platelet transfusions in patients who are nonthrombocytopenic and have cardiac surgery with cardiopulmonary bypass.

The AABB also suggests (without recommending) that patients with perioperative bleeding and thrombocytopenia or platelet dysfunction may benefit from transfusions.

Finally, the AABB said it cannot recommend for or against platelet transfusions in patients receiving antiplatelet therapy who have intracranial hemorrhage (traumatic or spontaneous).

For more details, see the complete guidelines in Annals of Internal Medicine.

Recommended Reading

Study supports 2:1 ratio for transfusion in pregnancy
MDedge Hematology and Oncology
Artificial platelets halt bleeding faster
MDedge Hematology and Oncology
Sugar beets can be used to create hemoglobin
MDedge Hematology and Oncology
Study reveals gap in patient blood management
MDedge Hematology and Oncology
Results support transfusing with caution in TTP, HIT
MDedge Hematology and Oncology
Transfusions benefit adults with sickle cell disease
MDedge Hematology and Oncology
Number of cord blood units doesn’t affect survival
MDedge Hematology and Oncology
Residents arrange transfusions despite poor knowledge
MDedge Hematology and Oncology
Newer blood linked to fewer complications from heart surgery
MDedge Hematology and Oncology
RECESS suggests RBC age doesn’t affect outcomes
MDedge Hematology and Oncology